Biofilm Removal Rate Testing for Medical Devices

Biofilm removal rate testing is a specialized laboratory study that quantifies how effectively a cleaning or disinfection process eliminates microbial biofilms from reusable medical devices and their material surfaces. Because biofilms embedded in extracellular polymeric substances are dramatically more resistant to antimicrobial agents than free-floating bacteria, demonstrating their removal is essential for validating reprocessing instructions and supporting regulatory compliance with ISO, ASTM, and EN standards. This article explains the technical principles, sample types, test parameters, methodologies, and applications of biofilm removal rate experiments conducted by accredited third-party laboratories.

Technical Overview

Biofilms are structured communities of microorganisms that adhere to surfaces and encase themselves in a self-produced matrix of extracellular polymeric substances (EPS), consisting primarily of polysaccharides, proteins, and extracellular DNA. On reusable medical devices, biofilms preferentially form in narrow lumens, hinges, crevices, and rough or damaged surfaces where residual organic soil and moisture persist after incomplete cleaning. Once established, biofilm-embedded organisms can exhibit resistance to disinfectants that is several orders of magnitude higher than that of planktonic cells, creating a serious risk of healthcare-associated infections and cross-contamination between patients.

A biofilm removal rate experiment is a controlled laboratory study designed to quantify the ability of a cleaning agent, detergent, disinfectant, or automated reprocessing cycle to remove and inactivate biofilm. In the study, a standardized, reproducible biofilm is first cultivated on the device surface or on representative material coupons using validated biofilm reactor models. The test article is then subjected to the cleaning process under evaluation, typically under worst-case conditions. The quantity of residual biofilm is subsequently measured and compared with the untreated control, yielding a removal rate percentage and a logarithmic (log) reduction value.

This testing supports the validation obligations of medical device manufacturers, including the development of processing information required by ISO 17664 and performance demonstration aligned with the ISO/TS 15883 series for washer-disinfectors. Standardized biofilm methods published by ASTM International, such as ASTM E2562, ASTM E2196, ASTM E2647, and ASTM E2871, provide the experimental foundation for reproducible biofilm growth, treatment, and enumeration in these studies.

Testing Samples

Endoscopes and Endoscope Channels

Flexible and rigid endoscopes contain long, narrow working channels that are notoriously difficult to clean and are among the most frequently implicated devices in biofilm-related contamination events. Testing may be performed on entire channels, sectioned channel segments, or glass and polymer tubes that simulate channel geometry, inoculated with clinically relevant organisms and processed through manual or automated cleaning protocols.

Surgical Instruments

Reusable surgical instruments with hinges, box locks, serrations, and mated surfaces are tested to evaluate whether cleaning procedures can disrupt biofilm harbored in inaccessible crevices. Simulated-use soiling with organic challenge materials, followed by biofilm development and reprocessing, reflects realistic clinical conditions.

Dental Devices

Dental handpieces, scalers, and prophylaxis angles encounter high microbial loads and aerosols. Biofilm removal testing verifies that recommended cleaning and sterilization workflows eliminate microbial communities from internal water lines and external working surfaces.

Catheters and Tubular Devices

Urinary and intravascular catheters, along with other fluid-path devices, are evaluated for biofilm susceptibility and cleanability, since biofilm formation on such devices is a leading cause of device-associated infection.

Material Test Coupons

When whole devices cannot be sacrificed, standardized coupons made from the same materials as the device, such as stainless steel, polytetrafluoroethylene (PTFE), polypropylene, glass, or silicone, are used as substrate proxies. Coupons enable controlled biofilm growth under conditions defined in ASTM reactor methods and allow direct quantitative comparison between surface treatments or coatings.

Testing Items

Depending on the study objective, the following parameters are typically measured and reported:

• Initial biofilm burden on control articles, expressed as log CFU per square centimeter or per test article
• Residual viable biofilm organisms after the cleaning or disinfection treatment
• Biofilm removal rate expressed as a percentage of biomass eliminated relative to the untreated control
• Log reduction of viable biofilm bacteria achieved by the process
• Total residual organic soil, measured as total organic carbon (TOC), protein, carbohydrate, or hemoglobin
• Residual endotoxin levels where clinically relevant
• Surface biofilm coverage and architecture assessed by microscopy, including viable and nonviable cell discrimination
• Comparative performance of different detergents, contact times, temperatures, or mechanical actions

Testing Methods

Biofilm Development

Reference strains such as Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Enterococcus faecalis are commonly used, either as single-species or mixed-species biofilms. Biofilms are cultivated under shear stress in validated reactor systems, including the CDC biofilm reactor (ASTM E2562), the rotating disk reactor (ASTM E2196), the drip flow reactor (ASTM E2647), or the MBEC high-throughput assay platform, until a mature, reproducible biofilm with a defined density is achieved, typically within 24 to 72 hours of growth.

Cleaning Treatment

The biofilm-laden test articles are exposed to the cleaning agent, disinfectant, or reprocessing cycle under evaluation. Critical process variables are controlled and documented, including detergent concentration, water temperature, exposure duration, mechanical action such as brushing or ultrasonic cavitation, and rinsing conditions. Testing under deliberately challenging, worst-case parameters strengthens the validity of the conclusions drawn for real-world use.

Quantification and Calculation

After treatment, residual biofilm is detached from the surface using validated recovery techniques such as sonication combined with vortexing, and the recovered organisms are enumerated by serial dilution and plate counting. The removal rate and microbial inactivation are then calculated:

• Removal rate (%) = (Quantity in untreated control − Quantity after treatment) ÷ Quantity in untreated control × 100
• Log reduction = log10 (Quantity in untreated control) − log10 (Quantity after treatment)

Results are interpreted against predefined acceptance criteria established in the study protocol, which may reference cleaning benchmarks described in ISO/TS 15883-5 for test soils and cleaning efficacy methods.

Complementary Analytical Methods

To characterize biofilm mass and viability beyond culture-based counting, laboratories apply confocal laser scanning microscopy with fluorescent live/dead staining, crystal violet biomass staining, ATP bioluminescence assays, and specific protein or TOC analysis of extracted residues. These orthogonal methods confirm whether the cleaning process physically removes the biofilm matrix rather than merely killing embedded cells, which is a critical distinction for preventing accumulation of residual organic burden over repeated reprocessing cycles.

Applications

Biofilm removal rate experiments serve multiple stakeholders across the medical device lifecycle:

• Validation of cleaning instructions for use provided by device manufacturers in accordance with ISO 17664
• Performance qualification of automated washer-disinfectors aligned with the ISO/TS 15883 series
• Research and development of enzymatic detergents, surfactant formulations, and antimicrobial surface coatings
• Substantiation of comparative efficacy claims for cleaning chemistries and reprocessing protocols
• Support for regulatory submissions and design dossiers that require objective evidence of cleanability
• Verification of hospital reprocessing procedures following contamination investigations or protocol changes
• Evaluation of anti-biofilm or antimicrobial device claims under simulated-use conditions

FAQ

Which microorganisms are most commonly used in biofilm removal studies?

Pseudomonas aeruginosa is the most frequently selected organism because it is a strong biofilm former and a recognized standard strain in ASTM biofilm methods. Staphylococcus aureus and Staphylococcus epidermidis are added for gram-positive coverage, and mixed-species biofilms can be engineered when a more clinically representative challenge is required.

What removal or reduction level is considered acceptable?

Acceptance criteria are protocol-specific, but many cleaning validation studies target a reduction of several logarithms in viable biofilm organisms combined with near-complete elimination of detectable organic residue. The criteria should be justified based on the intended use of the device, the toxicity of residual soil, and recognized national and international guidance.

How long does a biofilm removal rate study take?

A typical study requires several weeks, accounting for biofilm cultivation, treatment exposure, incubation of enumeration plates, and repeat runs to confirm reproducibility. More complex protocols involving multiple detergents, mixed-species biofilms, or microscopy-based endpoints may extend the timeline further.

Can testing be performed on an actual finished device rather than coupons?

Yes. Whole devices or clinically relevant components, such as endoscope channel sections, can be inoculated and reprocessed to generate simulated-use evidence. Coupon-based testing remains valuable as a screening and comparison tool because it offers superior experimental control and repeatability.

How should samples be submitted for testing?

Manufacturers should provide clean, non-sterile representative devices or material coupons together with detailed processing instructions, including the detergent, concentration, temperature, exposure time, and equipment to be simulated. A clearly defined study protocol with acceptance criteria should be agreed upon with the accredited third-party laboratory before testing begins.